Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)
Fury, M. G., Sherman, E. J., Rao, S. S., Wolden, S., Smith-Marrone, S., Mueller, B., Ng, K. K., Dutta, P. R., Gelblum, D. Y., Lee, J. L., Shen, R., Kurz, S., Katabi, N., Haque, S., Lee, N. Y., PfisterVolume:
25
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdt579
Date:
March, 2014
File:
PDF, 112 KB
english, 2014